March 25, 2020

D&O Insurance: What Life Sciences Companies and their Directors and Officers Need to Know


The last few years have seen a dramatic rise in the number of securities class-action cases involving initial public offerings, and this has affected D&O coverage and the costs associated with D&O insurance.

During this webcast, Mike Ferraro and Yelena Dunaevsky from Woodruff Sawyer will address:

  • What are the risks to directors and officers?
  • Why should you consider purchasing D&O insurance?
  • Basics of D&O coverage for both private and public companies;
  • When should you begin D&O insurance discussions?
  • The IPO market – integrating the D&O process into your S-1 timeline and current premium trends for IPOs;
  • Recent securities litigation trends and the effect on the D&O insurance market; and
  • How settlement data can help drive the decision for appropriate limits.

Additional Speakers

Michael Ferraro
Woodruff Sawyer

Yelena Dunaevsky
Woodruff Sawyer

United States
1:00 p.m. – 2:00 p.m. EDT
12:00 p.m. – 1:00 p.m. CDT
11:00 a.m. – 12:00 p.m. MDT
10:00 a.m. – 11:00 a.m. PDT

5:00 p.m. – 6:00 p.m. BST
6:00 p.m. – 7:00 p.m. CEST

Stay Up To Date With Our Insights

See how we use a multidisciplinary, integrated approach to meet our clients' needs.